Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6‐OHDA lesioned rat
Identifieur interne : 000E59 ( Main/Exploration ); précédent : 000E58; suivant : 000E60Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6‐OHDA lesioned rat
Auteurs : Anna R. Carta [Italie] ; Frau Lucia [Italie] ; Pinna Annalisa [Italie] ; Pontis Silvia [Italie] ; Simola Nicola [Italie] ; Schintu Nicoletta [Italie] ; Morelli Micaela [Italie]Source :
- Synapse [ 0887-4476 ] ; 2008-07.
English descriptors
- KwdEn :
Abstract
Prolonged treatment with L‐DOPA induces highly disabling dyskinesia in Parkinson's disease (PD) patients. In contrast, dopaminergic agonists display variably dyskinetic outcome, depending on pharmacokinetic/pharmacodynamic profile. The present study was aimed at assessing behavioral and biochemical correlates of intense or mild dyskinesia displayed by the different dopamine (DA) receptors stimulation in a rat model of PD. The effect of subchronic stimulation of the D1 receptor by SKF38393, and the D2/D3 receptor by ropinirole was evaluated in unilaterally 6‐hydroxyDA‐lesioned rats. Sensitization of contralateral turning (SCT) behavior and abnormal involuntary movements (AIMs) were assessed as behavioral correlates of dyskinetic responses. Opioid peptides mRNA in the dorsolateral striatum (dlStr) and glutamic acid decarboxylase (GAD67) mRNA content in globus pallidus (GP), were evaluated as an index of neuroadaptive changes occurring in the direct and indirect basal ganglia pathways. Subchronic SKF38393 caused AIMs and SCT whereas ropinirole elicited SCT only, indicating that both drugs induced some dyskinetic response, albeit of different type. Peptides mRNA evaluation in dlStr, showed that SKF38393 subchronic treatment was associated to an overexpression of both dynorphin (DYN) and enkephalin (ENK) mRNAs, in the direct and indirect striatal pathway respectively. In contrast, a decrease in DYN mRNA levels only was observed after treatment with ropinirole. Analysis of GAD67 mRNA levels in the GP showed an increase after both D1 and D2/D3 agonist treatments. Results suggest that presence of SCT alone or SCT plus AIMs might represent correlates of the differential severity of dyskinetic movements induced by treatment with low (ropinirole) or high (SKF38393) dyskinetic potential. Neuroadaptive increases in opioid peptide expression in both direct and indirect striatal pathways were associated to the appearance of AIMs alone. In contrast, increase of GAD67 mRNA in the GP was associated to both behavioral responses (SCT and AIMs), suggesting that neuroadaptive changes in this area were unrelated to the difference in dyskinetic potential of drugs. drugs. Synapse 62:524–533, 2008. © 2008 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/syn.20527
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6‐OHDA lesioned rat</title><author><name sortKey="Carta, Anna R" sort="Carta, Anna R" uniqKey="Carta A" first="Anna R." last="Carta">Anna R. Carta</name></author><author><name sortKey="Lucia, Frau" sort="Lucia, Frau" uniqKey="Lucia F" first="Frau" last="Lucia">Frau Lucia</name></author><author><name sortKey="Annalisa, Pinna" sort="Annalisa, Pinna" uniqKey="Annalisa P" first="Pinna" last="Annalisa">Pinna Annalisa</name></author><author><name sortKey="Silvia, Pontis" sort="Silvia, Pontis" uniqKey="Silvia P" first="Pontis" last="Silvia">Pontis Silvia</name></author><author><name sortKey="Nicola, Simola" sort="Nicola, Simola" uniqKey="Nicola S" first="Simola" last="Nicola">Simola Nicola</name></author><author><name sortKey="Nicoletta, Schintu" sort="Nicoletta, Schintu" uniqKey="Nicoletta S" first="Schintu" last="Nicoletta">Schintu Nicoletta</name></author><author><name sortKey="Micaela, Morelli" sort="Micaela, Morelli" uniqKey="Micaela M" first="Morelli" last="Micaela">Morelli Micaela</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:1C59D2570C6986525326A362EEB4254A7D33034C</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/syn.20527</idno><idno type="url">https://api.istex.fr/document/1C59D2570C6986525326A362EEB4254A7D33034C/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001384</idno><idno type="wicri:Area/Main/Curation">001172</idno><idno type="wicri:Area/Main/Exploration">000E59</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6‐OHDA lesioned rat</title><author><name sortKey="Carta, Anna R" sort="Carta, Anna R" uniqKey="Carta A" first="Anna R." last="Carta">Anna R. Carta</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Toxicology and Center of Excellence for Neurobiology of Addiction, University of Cagliari, 09124 Cagliari</wicri:regionArea><wicri:noRegion>09124 Cagliari</wicri:noRegion></affiliation></author><author><name sortKey="Lucia, Frau" sort="Lucia, Frau" uniqKey="Lucia F" first="Frau" last="Lucia">Frau Lucia</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Toxicology and Center of Excellence for Neurobiology of Addiction, University of Cagliari, 09124 Cagliari</wicri:regionArea><wicri:noRegion>09124 Cagliari</wicri:noRegion></affiliation></author><author><name sortKey="Annalisa, Pinna" sort="Annalisa, Pinna" uniqKey="Annalisa P" first="Pinna" last="Annalisa">Pinna Annalisa</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>CNR Institute of Neuroscience, Section of Cagliari, 09124 Cagliari</wicri:regionArea><wicri:noRegion>09124 Cagliari</wicri:noRegion></affiliation></author><author><name sortKey="Silvia, Pontis" sort="Silvia, Pontis" uniqKey="Silvia P" first="Pontis" last="Silvia">Pontis Silvia</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Toxicology and Center of Excellence for Neurobiology of Addiction, University of Cagliari, 09124 Cagliari</wicri:regionArea><wicri:noRegion>09124 Cagliari</wicri:noRegion></affiliation></author><author><name sortKey="Nicola, Simola" sort="Nicola, Simola" uniqKey="Nicola S" first="Simola" last="Nicola">Simola Nicola</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Toxicology and Center of Excellence for Neurobiology of Addiction, University of Cagliari, 09124 Cagliari</wicri:regionArea><wicri:noRegion>09124 Cagliari</wicri:noRegion></affiliation></author><author><name sortKey="Nicoletta, Schintu" sort="Nicoletta, Schintu" uniqKey="Nicoletta S" first="Schintu" last="Nicoletta">Schintu Nicoletta</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Toxicology and Center of Excellence for Neurobiology of Addiction, University of Cagliari, 09124 Cagliari</wicri:regionArea><wicri:noRegion>09124 Cagliari</wicri:noRegion></affiliation></author><author><name sortKey="Micaela, Morelli" sort="Micaela, Morelli" uniqKey="Micaela M" first="Morelli" last="Micaela">Morelli Micaela</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Toxicology and Center of Excellence for Neurobiology of Addiction, University of Cagliari, 09124 Cagliari</wicri:regionArea><wicri:noRegion>09124 Cagliari</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>CNR Institute of Neuroscience, Section of Cagliari, 09124 Cagliari</wicri:regionArea><wicri:noRegion>09124 Cagliari</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Synapse</title><title level="j" type="abbrev">Synapse</title><idno type="ISSN">0887-4476</idno><idno type="eISSN">1098-2396</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-07">2008-07</date><biblScope unit="volume">62</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="524">524</biblScope><biblScope unit="page" to="533">533</biblScope></imprint><idno type="ISSN">0887-4476</idno></series><idno type="istex">1C59D2570C6986525326A362EEB4254A7D33034C</idno><idno type="DOI">10.1002/syn.20527</idno><idno type="ArticleID">SYN20527</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0887-4476</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIMs</term><term>D1 agonist</term><term>GAD67</term><term>dynorphin</term><term>dyskinesia</term><term>enkephalin</term><term>ropinirole</term><term>turning</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Prolonged treatment with L‐DOPA induces highly disabling dyskinesia in Parkinson's disease (PD) patients. In contrast, dopaminergic agonists display variably dyskinetic outcome, depending on pharmacokinetic/pharmacodynamic profile. The present study was aimed at assessing behavioral and biochemical correlates of intense or mild dyskinesia displayed by the different dopamine (DA) receptors stimulation in a rat model of PD. The effect of subchronic stimulation of the D1 receptor by SKF38393, and the D2/D3 receptor by ropinirole was evaluated in unilaterally 6‐hydroxyDA‐lesioned rats. Sensitization of contralateral turning (SCT) behavior and abnormal involuntary movements (AIMs) were assessed as behavioral correlates of dyskinetic responses. Opioid peptides mRNA in the dorsolateral striatum (dlStr) and glutamic acid decarboxylase (GAD67) mRNA content in globus pallidus (GP), were evaluated as an index of neuroadaptive changes occurring in the direct and indirect basal ganglia pathways. Subchronic SKF38393 caused AIMs and SCT whereas ropinirole elicited SCT only, indicating that both drugs induced some dyskinetic response, albeit of different type. Peptides mRNA evaluation in dlStr, showed that SKF38393 subchronic treatment was associated to an overexpression of both dynorphin (DYN) and enkephalin (ENK) mRNAs, in the direct and indirect striatal pathway respectively. In contrast, a decrease in DYN mRNA levels only was observed after treatment with ropinirole. Analysis of GAD67 mRNA levels in the GP showed an increase after both D1 and D2/D3 agonist treatments. Results suggest that presence of SCT alone or SCT plus AIMs might represent correlates of the differential severity of dyskinetic movements induced by treatment with low (ropinirole) or high (SKF38393) dyskinetic potential. Neuroadaptive increases in opioid peptide expression in both direct and indirect striatal pathways were associated to the appearance of AIMs alone. In contrast, increase of GAD67 mRNA in the GP was associated to both behavioral responses (SCT and AIMs), suggesting that neuroadaptive changes in this area were unrelated to the difference in dyskinetic potential of drugs. drugs. Synapse 62:524–533, 2008. © 2008 Wiley‐Liss, Inc.</div></front></TEI><affiliations><list><country><li>Italie</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Carta, Anna R" sort="Carta, Anna R" uniqKey="Carta A" first="Anna R." last="Carta">Anna R. Carta</name></noRegion><name sortKey="Annalisa, Pinna" sort="Annalisa, Pinna" uniqKey="Annalisa P" first="Pinna" last="Annalisa">Pinna Annalisa</name><name sortKey="Lucia, Frau" sort="Lucia, Frau" uniqKey="Lucia F" first="Frau" last="Lucia">Frau Lucia</name><name sortKey="Micaela, Morelli" sort="Micaela, Morelli" uniqKey="Micaela M" first="Morelli" last="Micaela">Morelli Micaela</name><name sortKey="Micaela, Morelli" sort="Micaela, Morelli" uniqKey="Micaela M" first="Morelli" last="Micaela">Morelli Micaela</name><name sortKey="Nicola, Simola" sort="Nicola, Simola" uniqKey="Nicola S" first="Simola" last="Nicola">Simola Nicola</name><name sortKey="Nicoletta, Schintu" sort="Nicoletta, Schintu" uniqKey="Nicoletta S" first="Schintu" last="Nicoletta">Schintu Nicoletta</name><name sortKey="Silvia, Pontis" sort="Silvia, Pontis" uniqKey="Silvia P" first="Pontis" last="Silvia">Pontis Silvia</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E59 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000E59 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:1C59D2570C6986525326A362EEB4254A7D33034C
|texte= Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6‐OHDA lesioned rat
}}
| This area was generated with Dilib version V0.6.23. |  |